基于患者结果的实时质控用于定量乙肝病毒DNA检测:利用阳性与阴性结果的移动率
本研究将基于患者结果的实时质控(PBRTQC)引入定量乙肝病毒(HBV)DNA检测,采用阳性与阴性患者结果的移动率(MR)方案,并在2018年8月至2021年8月广州中医药大学第二附属医院的HBV-DNA检测患者结果上进行参数设置、优化与性能验证。两种MR方案的假拒绝率均低于0.7%,且针对不同截断值的正负误差,最佳区块大小不同,因此首次提出使用不同区块大小检测负误差和正误差的组合方案,其性能优于简单方案,尤其在检测正误差方面。结论提示,利用阳性或阴性患者结果的MR方案检测HBV-DNA检测的恒定误差可满足实验室要求,为分子诊断领域的内部质量控制提供了有效替代工具。
要点
- PBRTQC首次应用于分子诊断领域的定量HBV-DNA检测。
- 两种MR方案的假拒绝率均低于0.7%。
- 组合方案(不同区块大小)优于简单方案,尤其检测正误差。
核心结论
- 利用阳性或阴性患者结果的移动率方案检测HBV-DNA检测的恒定误差,性能可满足实验室要求。
研究设计与样本
- 研究使用2018年8月至2021年8月广州中医药大学第二附属医院HBV-DNA检测的所有患者结果进行参数设置、优化和性能验证。
- MR方案在常用统计过程控制算法前增加了对数变换和二值转换步骤。
- 采用假拒绝率、误差检测曲线和验证图评估MR方案。
主要发现
- 两种MR方案的假拒绝率均低于0.7%。
- 每个截断值下检测正误差和负误差的最佳区块大小不相同。
- 组合方案在每个截断值下均优于简单方案,尤其在检测正误差方面。
关键数值与推荐
- 两种MR方案的假拒绝率均<0.7%。
- 每个截断值下检测正误差和负误差的最佳区块大小不相同。
临床怎么用
- 可将基于阳性或阴性患者结果移动率的PBRTQC方案作为分子诊断内部质量控制的替代工具。
- 针对正误差和负误差可采用不同区块大小的组合方案以提升检测性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patient-based real-time quality control (PBRTQC) has gained increasing attention in the field of laboratory quality management in recent years. However, PBRTQC has not been reported for use in molecular diagnostics. This study introduces PBRTQC to quantitative hepatitis B virus (HBV) DNA test using moving rate (MR) of positive and negative patient results. METHODS: In contrast to the MR protocols described in other literature, MR protocol for HBV-DNA test has an additional logarithmic transformation and binary conversion steps before using a common statistical process control algorithm, such as the MR. We used all patient test results of HBV-DNA assay from August 2018 to August 2021 at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, for parameters setting, optimization, and performance validation. The false rejection rate, error detection curves and validation charts were used to assess the MR protocols. RESULTS: The false rejection rates of two MR protocols were both <0.7%. The optimal block sizes for positive and negative errors in each cut-off value were not the same, so we first proposed a combined protocol that used different block size to detect negative and positive errors. It turned out that the combined protocols outperformed the simple protocols for each cut-off value, especially detecting positive errors. CONCLUSIONS: The performances of MR protocols using positive or negative patient results to detect constant errors of HBV-DNA test could meet laboratory requirements. Therefore, we have provided an effective alternative tool for internal quality control in the field of molecular diagnostics.
引用
- Li T, Li J, Cao S, et al. Patient-based real-time quality control for quantitative hepatitis B virus DNA test using moving rate of positive and negative patient results. Clin Chem Lab Med. 2022. PMID: 35822704. doi:10.1515/cclm-2022-0338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。